Striving for equity: Patient prioritization during a critical cancer drug shortage-Reference-Cited by-同舟云学术

Striving for equity: Patient prioritization during a critical cancer drug shortage

Author:

Lee Brittany M.¹²³^ORCID,Jecker Nancy S.⁴⁵,Marron Jonathan M.⁶⁷^ORCID,Rosenberg Abby R.²³^ORCID

Affiliation:

1. Treuman Katz Center for Pediatric Bioethics Seattle Children's Hospital and Research Institute Seattle Washington USA

2. Department of Pediatrics, Division of Hematology/Oncology University of Washington School of Medicine Seattle Washington USA

3. Palliative Care and Resilience Lab Seattle Children's Research Institute Seattle Washington USA

4. Department of Bioethics and Humanities University of Washington School of Medicine Seattle Washington USA

5. Fulbright U.S. Scholar Program University of Johannesburg Johannesburg Gauteng South Africa

6. Dana‐Farber/Boston Children's Cancer and Blood Disorders Center Harvard Medical School Boston Massachusetts USA

7. Center for Bioethics Harvard Medical School Boston Massachusetts USA

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology, and Child Health

Link

Reference29 articles.

5. FDA drug shortages. Asparaginase Erwinia chrysanthemi (Erwinaze). U.S. FDA.2021. Accessed April 30 2021.

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献